The effect of vitamin D on insulin resistance in patients with type 2 diabetes

Diabetology and Metabolic Syndrome

Volumn 5, Issue 1, 2013, Pages

  Talaei, Afsaneh ^a   Mohamadi, Mahnaz ^a   Adgi, Zahra ^a  

^a ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes; Insulin resistance; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL; GLUCOSE; INSULIN;

ADULT; AGED; ARTICLE; DIABETIC PATIENT; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; VITAMIN SUPPLEMENTATION;

EID: 84874196938     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-5-8     Document Type: Article

References (36)

1. Vitamin D and disease prevention with special reference to cardiovascular disease. Zittermann A, Prog Biophys Mol Biol 2006 92 39 48 10.1016/j. pbiomolbio.2006.02.001 16600341 (Pubitemid 43831966)
2. Role of vitamin D in insulin secretion and insulin sensitivity for glucose Homeostasis. Alvarez JA, Ashraf A, Int J Endocrinal 2010 2010 351 385
3. Can vitamin D intake assist in improving the outcome of endodontic treatment for diabetic patients. Yingying S, Ling Y, Medical Hypotheses 2009 2 1 6
4. Vitamin D deficiency is the cause of common obesity. Foss YJ, Med Hypotheses 2009 72 3 314 321 10.1016/j.mehy.2008.10.005 19054627
5. Comment on vitamin D deficiency is the cause of common obesity. Zhang Z, Zhang Z, Med Hypotheses 2009 73 1 123 19285811
6. Serum 25- hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Mattila C, Knekt P, Mannisto S, Diabetes Care 2007 30 2569 2570 10.2337/dc07-0292 17626891 (Pubitemid 47547796)
7. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Palomer X, Gonzalez-Clemente JM, Blanco-Vaca F, Mauricio D, Diabetes Obes Metab 2008 10 185 197 10.1111/j.1463-1326.2007.00710.x 18269634 (Pubitemid 351249776)
8. Serumosteocalcin levels in diabetes mellitus: analysis of the type of diabetes and microvasculor complications. Pietschmann P, Schernthaner G, Woloszczuk W, Diabetologia 1988 31 892 895 3266486 (Pubitemid 19054759)
9. High Prevalence of hypovitaminosis D in female type 2 diabetic population. Isaia G, Giorgino R, Adami S, Diabetes Care 2001 24 1496 10.2337/diacare.24.8.1496 11473093
10. Vitamin D, glucose tolerance andinsulinaemia in elderly men. Baynes KC, Boucher BJ, Feskens EJ, Kromhout D, Diabtologia 1997 40 344 347 10.1007/s001250050685 (Pubitemid 27096561)
11. Effects of vitamin D3 on the pancreatic secretion of insulin andsomatostatin. Tanaka Y, Seino Y, Ishida M, Acta Endocrinal 1984 105 528 533 (Pubitemid 14171181)
12. Cellular mechanisms of insulin release: the effects of vitamin D deficiency and repletion on rat insulin secretion. Chertow BS, Sivitz WI, Baranetsky NG, Clark SA, Waite A, Endocrinology 1983 113 1511 1518 10.1210/endo-113-4-1511 6352248 (Pubitemid 13009167)
13. Transcriptional activation of the human insulin receptorgene by 1, 25-dihydroxyvitamin D(3). Maestro B, Molero S, Bajo S, Cell bio-chemfunct 2002 20 227 232
14. Efficacy and metabolic effect of metformin and troglitazone in type 2 Diabetes mellitus. Inzucchi SE, Maggs DG, Spollett GR, N Engl J Med 1998 338 13 867 872 10.1056/NEJM199803263381303 9516221 (Pubitemid 28135963)
15. Effects of vitamin D deficiency and repletion on insulin and glucagonssecretion in man. Gedik O, Akalin S, Diabetologia 1986 29 3 142 145 10.1007/BF02427083 3516771 (Pubitemid 16137021)
16. Vitamin D3 improres impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in viro. Cade C, Norman AW, Endocrinology 1986 119 1 84 90 10.1210/endo-119-1-84 3013599 (Pubitemid 16100711)
17. Hypovitaminosis D is associated with insulin resistance and Bcell dysfunction. Ken Chiu C, Audrey C, Am J Clin Nutr 2004 79 5 820 825 15113720
18. vitamin D deficiency and type 2 diabetes. Zehra O, Tahseen A, Postgrad Med J 2010 86 18 25 10.1136/pgmj.2009.078626 20065337
19. Diagnosis and classification of diabetes mellitus. American Diabetes Association, Diabetes Care 2005 28 1 37 42
20. Risk assessment by post-challenge plasma glucose, insulin response ratio, and other indices of insulin resistance and/or secretion for predicting the development of type 2 diabetes. Tanabe N, Saito K, Yamada Y, Inter Med 2009 48 401 409 10.2169/internalmedicine.48.1325
21. vitamin D supplementation reduces insulin resistance in south Asian Women living in New Zealand. Von Hurst PR, Stonehouse W, Coad J, Br J Nutr 2009 28 1 7
22. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in non-diabetic adults. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B, Diabetes Care 2007 30 4 980 986 10.2337/dc06-1994 17277040 (Pubitemid 46556596)
23. The effect of different doses of vitamin D3 on markers of vascular health. Witham MD, Dore FJ, Druburgh M, Sugden JA, Morris AD, Struthers AD, Diabetologia 2010 53 10 2112 2119 10.1007/s00125-010-1838-1 20596692
24. Long-term treatment with active vitamin D (alphacalcidol) in middle-aged men with impaired glucose tolerance, Effects on insulin secretion and sensitivity, glucose tolerance and blood pressure. Lind L, Pollare T, Hvarfner A, Lithell H, Sorensen OH, Ljunghall S, Diabetes Res 1989 11 3 141 147 2697485 (Pubitemid 20043680)
25. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Nagpal J, Pande JN, Bhartia A, Diabetic Medicine 2009 26 1 19 27 10.1111/j.1464-5491.2008.02636.x 19125756
26. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets. Bland R, Markovic D, Hills CE, Hughes SV, Chan SL, Squires PE, J Steroid BiochemMol Biol 2004 89-90 1-5 121 125 (Pubitemid 38844271)
27. Identification of a Vitamin D response element in the human insulin receptor gene promoter. Maestro B, Davila N, Carranza MC, Calle C, J Steroid BiochemMol Biol 2003 84 2-3 223 230 (Pubitemid 36514839)
28. Identification of 1, 25-dihydroxyvitamin D3 receptors and activities in muscle. Simpson RU, Thomas GA, Arnold AJ, J Biological Chemistry 1985 260 15 8882 8891 (Pubitemid 15011982)
29. A novel role for vitamin D: modulation of expression and function of the local renin-angiotensin system in mouse pancreatic islets. Cheng Q, Li YC, Boucher BJ, Leung PS, Diabetologia 2011 54 2077 2081 10.1007/s00125-011-2100-1 21424540
30. Role of calcium AMP kinase in the regulation of mitochondrial biogenesis and GLUT4 levels in muscle. Ojuka E, ProcNutrsoc 2004 63 275 278 (Pubitemid 38787478)
31. The human peroxisome proliferator-activated receptor δ gene is a primary target of 1α, 25-dihydroxyvitamin D3 and its nuclear receptor. Dunlop TW, Vaisanen S, Frank C, Molnar F, Sinkkonen L, Carlberg C, J Molecular Biology 2005 349 2 248 260 10.1016/j.jmb.2005.03.060 (Pubitemid 40693747)
32. The anti inflammatory activity of 1,25 dihydroxy vitamin D3 in macrophages. Cohen-Lahav M, Douvdevani A, Chaimovitz C, Shany S, J Steroid Biochem Mol Biol 2007 103 558 562 10.1016/j.jsbmb.2006.12.093 17267205 (Pubitemid 46401358)
33. Effect of Calcitriol on Glycemic and Lipid Control in Type 2 Diabetes. Bonakdaran S, Afkhami Zadeh M, Iran J Endocrinol Metab 2011 12 5) 513 519
34. The effect of parenteral vitamin D supplementation on insulin resistance and anthropometric factors in patients with diabetes type 2. Heshmat R, Tabatabaee O, Moradzade K, Abasszade S, Iran J Diabetes Lipid Disord 2011 10 5 492 501
35. Effect of Supplementary Vitamin D on Improvement of Glycemic Parameters in Patients with Type 2 Diabetic. Behradmanesh S, Roudini K, Baradaran A, J Isfahan Med Sch 2011 29 151 1098 1105
36. Effects of daily consumption of Iranian yogurt drink doogh fortified with vitamin D or vitamin D plus calcium on the anthropometric and glycemic indices in type-2 diabetes patients. Nikooyeh B, Neyestani T, Farvid M, Alavimajd H, Kalayi A, Shariat Zadeh N, Iran J Nutr Sci Food Technol 2011 6 3 20 29